Location History:
- Pittsburgh, PA (US) (2014)
- North Haven, CT (US) (2018 - 2021)
Company Filing History:
3 out of 919 
3 out of 1,866 
2 out of 2,347 
Years Active: 2014-2021
Title: Innovations by Jose David Herazo-Maya
Introduction
Jose David Herazo-Maya is an accomplished inventor based in North Haven, CT (US). He has made significant contributions to the field of medical research, particularly in the area of idiopathic pulmonary fibrosis (IPF). With a total of 4 patents, his work focuses on developing methods and tools to better predict and manage this challenging disease.
Latest Patents
Herazo-Maya's latest patents include groundbreaking innovations such as "Biomarkers for assessing idiopathic pulmonary fibrosis." This patent discloses methods and kits for evaluating whether an individual with IPF has a slowly or rapidly progressive form of the disease. Another notable patent is titled "52-gene signature in peripheral blood identifies a genomic profile associated with increased risk of mortality and poor disease outcomes in idiopathic pulmonary fibrosis." This patent addresses the difficulty in predicting the clinical course of IPF by describing a peripheral blood 52-gene expression signature that can improve outcome prediction.
Career Highlights
Throughout his career, Herazo-Maya has worked with prestigious institutions such as the University of Chicago and the University of Pittsburgh. His research has been instrumental in advancing the understanding of IPF and developing new diagnostic tools.
Collaborations
Some of his notable coworkers include Naftali Kaminski and Imre Noth, who have also contributed to the field of pulmonary research.
Conclusion
Jose David Herazo-Maya's innovative work in the field of idiopathic pulmonary fibrosis has the potential to significantly improve patient outcomes. His contributions through patents and collaborations highlight the importance of research in understanding and managing complex diseases.